Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The hypoglycemic drug SGLT2 inhibitors also shows promising therapeutic effect on diabetes-induced renal tubular damage by restoring autophagy (156)
The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for
If the inflammation of the large intestine subsides, but the visceral discomfort persists, the inflammation is likely to recur
Researchers unveiled details from clinical trials at the annual meeting of the American Diabetes Association in New Orleans
